A national study of outcomes among HIV-infected kidney transplant recipients

Journal of the American Society of Nephrology

Volumn 26, Issue 9, 2015, Pages 2222-2229

  Locke, Jayme E ^a   Mehta, Shikha ^a   Reed, Rhiannon D ^a   MacLennan, Paul ^a   Massie, Allan ^b   Nellore, Anoma ^a   Durand, Christine ^c   Segev, Dorry L ^b  

^a University of Alabama at Birmingham   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CAUSE OF DEATH; CHRONIC PATIENT; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OUTCOME ASSESSMENT; POPULATION; PRIORITY JOURNAL; TREATMENT DURATION; CASE CONTROL STUDY; COMPLICATION; EPIDEMIOLOGY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MIDDLE AGED; MORTALITY; PATIENT SELECTION; SURVIVAL RATE; UNITED STATES;

CASE-CONTROL STUDIES; COINFECTION; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEPATITIS C; HIV INFECTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; SURVIVAL RATE; UNITED STATES;

EID: 84937527381     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014070726     Document Type: Article

References (23)

1. Centers for Disease Control and Prevention: HIV in the United States: At a glance, 2013; http://www.cdc.gov/hiv/statistics/basics/ataglance. html. Accessed June 9, 2014
2. Palella FJ Jr, Delaney KM, Moorman AC, LovelessMO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD; HIV Outpatient Study Investigators: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl JMed 338: 853-860, 1998
3. Rao TK: Human immunodeficiency virus infection in end-stage renal disease patients. Semin Dial 16: 233-244, 2003
4. Ando M, Tsuchiya K, Nitta K: How to manage HIV-infected patients with chronic kidneydisease in theHAARTera. ClinExpNephrol 16:363-372, 2012
5. Blumberg EA, Stock P; AST Infectious Diseases Community of Practice: Solid organ transplantation in the HIV-infected patient. Am J Transplant 9[Suppl 4]: S131-S135, 2009
6. Wyatt CM, Murphy B: Kidney transplantation in HIV-infected patients. Semin Dial 18: 495-498, 2005
7. Kopp JB,Winkler C: HIV-associated nephropathy in African Americans. Kidney Int Suppl (83): S43-S49, 2003
8. Herman ES, Klotman PE: HIV-associated nephropathy: Epidemiology, pathogenesis, and treatment. Semin Nephrol 23: 200-208, 2003
9. US Renal Data System: USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States (Volume 2), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2009
10. Winston JA, Klotman PE: Arewe missing an epidemic ofHIV-associated nephropathy? J Am Soc Nephrol 7: 1-7, 1996
11. Stock PG, Barin B, Murphy B, Hanto D, Diego JM, Light J, Davis C, Blumberg E, Simon D, Subramanian A,Millis JM, Lyon GM, Brayman K, Slakey D, Shapiro R, Melancon J, Jacobson JM, Stosor V, Olson JL, Stablein DM, Roland ME: Outcomes of kidney transplantation in HIVinfected recipients. N Engl JMed 363: 2004-2014, 2010
12. Gathogo EN, Hamzah L, Hilton R,Marshall N, Ashley C, HarberM, Levy JB, Jones R, BoffitoM, Khoo SH, Drage M, Bhagani S, Post FA; UK HIV/ Kidney Transplantation Study Group (see appendix): Kidney transplantation inHIV-positive adults: The UK experience. Int J STDAIDS 25: 57-66, 2014
13. Malat GE, Ranganna KM, Sikalas N, Liu L, Jindal RM, Doyle A: High frequency of rejections in HIV-positive recipients of kidney transplantation: A single center prospective trial. Transplantation 94: 1020-1024, 2012
14. Mazuecos A, Fernandez A, Andres A, Gomez E, Zarraga S, Burgos D, Jimenez C, Paul J, Rodriguez-Benot A, Fernandez C: HIV infection and renal transplantation. Nephrol Dial Transplant 26: 1401-1407, 2011
15. Afdhal N, Zeuzem S, Kwo P, Chojkier M, Gitlin N, Puoti M, Romero-GomezM, Zarski JP, Agarwal K, Buggisch P, Foster GR, Brau N, Buti M, Jacobson IM, Subramanian GM, Ding X, Mo H, Yang JC, Pang PS, SymondsWT,McHutchison JG, Muir AJ, Mangia A, Marcellin P; ION-1 Investigators: Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med 370: 1889-1898, 2014
16. Sulkowski MS: Interferon-containing and interferon-free HCV therapy for HIV-infected patients. Semin Liver Dis 34: 72-78, 2014
17. Mikhalski D, Wissing KM, Ghisdal L, Broeders N, Touly M, Hoang AD, Loi P, Mboti F, Donckier V, Vereerstraeten P, Abramowicz D: Cold ischemia is amajor determinant of acute rejection and renal graft survival in the modern era of immunosuppression. Transplantation 85[Suppl]: S3-S9, 2008
18. Shoskes DA, Cecka JM: Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 66: 1697-1701, 1998
19. Kalble T, Alcaraz A, Budde K, Humke U, Karam G, Lucan M, Nicita G, Susal C: Guidelines on renal transplantation 10: 85, 2009
20. Troppmann C, Gillingham KJ, Benedetti E, Almond PS, Gruessner RW, Najarian JS, Matas AJ: Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation 59: 962-968, 1995
21. Locke JE, Montgomery RA, Warren DS, Subramanian A, Segev DL: Renal transplant in HIV-positive patients: Long-term outcomes and risk factors for graft loss. Arch Surg 144: 83-86, 2009
22. Kumar MS, Sierka DR, Damask AM, Fyfe B, McAlack RF, Heifets M, Moritz MJ, Alvarez D, Kumar A: Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients. Kidney Int 67: 1622-1629, 2005
23. Granville DJ, Tashakkor B, Takeuchi C, Gustafsson AB, Huang C, Sayen MR,Wentworth P Jr, YeagerM,Gottlieb RA: Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors. Proc Natl Acad Sci U S A 101: 1321-1326, 2004